Molecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loop

Virology

Volumn 381, Issue 2, 2008, Pages 222-229

  Leal, Élcio ^a   Silva, Wilson P ^a   Sucupira, Maria C ^a   Janini, L Mário ^a   Diaz, Ricardo S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

3D structure; CCR5; Coreceptor; CXCR4; GWGR; HIV 1; V3 loop

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; TETRAMER; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BRAZIL; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHENOTYPE; PHYLOGENETIC TREE; PRIORITY JOURNAL; STRUCTURE ANALYSIS; VIRUS MORPHOLOGY;

AMINO ACID SEQUENCE; ASPARTIC ACID; BRAZIL; EVOLUTION, MOLECULAR; GLUTAMIC ACID; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 54549086451     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.08.029     Document Type: Article

References (41)

1. Berger E.A., Murphy P.M., and Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17 (1999) 657-700
2. Boyd M.T., Simpson G.R., Cann A.J., Johnson M.A., and Weiss R.A. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J. Virol. 67 6 (1993) 3649-3652
3. Canutescu A.A., Shelenkov A.A., and Dunbrack Jr. R.L. A graph-theory algorithm for rapid protein side-chain prediction. Protein. Sci. 12 9 (2003) 2001-2014
4. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., and Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85 7 (1996) 1135-1148
5. Coakley E., Petropoulos C.J., and Whitcomb J.M. Assessing chemokine co-receptor usage in HIV. Curr. Opin. Infect. Dis. 18 1 (2005) 9-15
6. da Silva J. Site-specific amino acid frequency, fitness and the mutational landscape model of adaptation in human immunodeficiency virus type 1. Genetics 174 3 (2006) 1689-1694
7. Dacheux L., Moreau A., Ataman-Onal Y., Biron F., Verrier B., and Barin F. Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope. J. Virol. 78 22 (2004) 12625-12637
8. De Jong J.J., De Ronde A., Keulen W., Tersmette M., and Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66 11 (1992) 6777-6780
9. Frost S.D., Wrin T., Smith D.M., Kosakovsky Pond S.L., Liu Y., Paxinos E., Chappey C., Galovich J., Beauchaine J., Petropoulos C.J., Little S.J., and Richman D.D. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U. S. A. 102 51 (2005) 18514-18519
10. Huang C.C., Lam S.N., Acharya P., Tang M., Xiang S.H., Hussan S.S., Stanfield R.L., Robinson J., Sodroski J., Wilson I.A., Wyatt R., Bewley C.A., and Kwong P.D. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317 5846 (2007) 1930-1934
11. Huelsenbeck J.P., and Ronquist F. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17 8 (2001) 754-755
12. Hung C.S., Vander Heyden N., and Ratner L. Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization. J. Virol. 73 10 (1999) 8216-8226
13. Jensen M.A., Li F.S., van 't Wout A.B., Nickle D.C., Shriner D., He H.X., McLaughlin S., Shankarappa R., Margolick J.B., and Mullins J.I. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J. Virol. 77 24 (2003) 13376-13388
14. Kuiken C.L., and Leitner T. HIV-1 subtyping. In: a. G. R. L. Rodrigo A.G (Ed). Computational and evolutionary analysis of HIV molecular sequences Volume 1 (1999), Kluwer Academic Publisher, Norwell, Massachusetts, USA 27-53
15. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., and Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393 6686 (1998) 648-659
16. Leal E., Janini M., and Diaz R.S. Selective pressures of human immunodeficiency virus type 1 (HIV-1) during pediatric infection. Infect. Genet. Evol. 7 6 (2007) 694-707
17. Lemey P., Kosakovsky Pond S.L., Drummond A.J., Pybus O.G., Shapiro B., Barroso H., Taveira N., and Rambaut A. Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS. Comput. Biol. 3 2 (2007) e29
18. Lusso P., Earl P.L., Sironi F., Santoro F., Ripamonti C., Scarlatti G., Longhi R., Berger E.A., and Burastero S.E. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains. J. Virol. 79 11 (2005) 6957-6968
19. Meng G., Wei X., Wu X., Sellers M.T., Decker J.M., Moldoveanu Z., Orenstein J.M., Graham M.F., Kappes J.C., Mestecky J., Shaw G.M., and Smith P.D. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat. Med. 8 2 (2002) 150-156
20. Morgado M.G., Sabino E.C., Shpaer E.G., Bongertz V., Brigido L., Guimaraes M.D., Castilho E.A., Galvao-Castro B., Mullins J.I., and Hendry R.M. V3 region polymorphisms in HIV-1 from Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS. Res. Hum. Retroviruses. 10 5 (1994) 569-576
21. Ogert R.A., Lee M.K., Ross W., Buckler-White A., Martin M.A., and Cho M.W. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J. Virol. 75 13 (2001) 5998-6006
22. Potts K.E., Kalish M.L., Lott T., Orloff G., Luo C.C., Bernard M.A., Alves C.B., Badaro R., Suleiman J., and Ferreira O. Genetic heterogeneity of the V3 region of the HIV-1 envelope glycoprotein in Brazil. Brazilian Collaborative AIDS Research Group. Aids 7 9 (1993) 1191-1197
23. Rizzuto C.D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P.D., Hendrickson W.A., and Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280 5371 (1998) 1949-1953
24. Rosen O., Sharon M., Quadt-Akabayov S.R., and Anglister J. Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion. Proc. Natl. Acad. Sci. U. S. A. 103 38 (2006) 13950-13955
25. Ross H.A., and Rodrigo A.G. Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J. Virol. 76 22 (2002) 11715-11720
26. Roux K.H., and Taylor K.A. AIDS virus envelope spike structure. Curr. Opin. Struct. Biol. 17 2 (2007) 244-252
27. Sander O., Sing T., Sommer I., Low A.J., Cheung P.K., Harrigan P.R., Lengauer T., and Domingues F.S. Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage. PLoS. Comput. Biol. 3 3 (2007) e58
28. Santoro-Lopes G., Harrison L.H., Tavares M.D., Xexeo A., Dos Santos A.C., and Schechter M. HIV disease progression and V3 serotypes in Brazil: is B different from B-Br?. AIDS Res. Hum. Retroviruses. 16 10 (2000) 953-958
29. Scarlatti G., Tresoldi E., Bjorndal A., Fredriksson R., Colognesi C., Deng H.K., Malnati M.S., Plebani A., Siccardi A.G., Littman D.R., Fenyo E.M., and Lusso P. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3 11 (1997) 1259-1265
30. Schuitemaker H., Koot M., Kootstra N.A., Dercksen M.W., de Goede R.E., van Steenwijk R.P., Lange J.M., Schattenkerk J.K., Miedema F., and Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66 3 (1992) 1354-1360
31. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., and Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73 12 (1999) 10489-10502
32. Shioda T., Levy J.A., and Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349 6305 (1991) 167-169
33. Silva W.P., Santos D.E., Leal E., Brunstein A., Sucupira M.C., Sabino E.C., and Diaz R.S. Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption. Virology 354 1 (2006) 35-47
34. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 24 (1997) 4876-4882
35. Watabe T., Kishino H., Okuhara Y., and Kitazoe Y. Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host. Genetics 172 3 (2006) 1385-1396
36. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar-Gonzalez J.F., Salazar M.G., Kilby J.M., Saag M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., and Shaw G.M. Antibody neutralization and escape by HIV-1. Nature 422 6929 (2003) 307-312
37. Williamson S. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol. Biol. Evol. 20 8 (2003) 1318-1325
38. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W., Gerard C., and Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384 6605 (1996) 179-183
39. Yang Z., Nielsen R., Goldman N., and Pedersen A.M. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155 1 (2000) 431-449
40. Yang W., Bielawski J.P., and Yang Z. Widespread adaptive evolution in the human immunodeficiency virus type 1 genome. J. Mol. Evol. 57 2 (2003) 212-221
41. Zhang M., Gaschen B., Blay W., Foley B., Haigwood N., Kuiken C., and Korber B. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14 12 (2004) 1229-1246